Patents by Inventor John Randall Slemmon

John Randall Slemmon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays to detect neurodegeneration
    Patent number: 10976325
    Abstract: Methods of measuring the amount of singly- or multiply-phosphorylated p217+ tau protein in a sample are provided. Methods of detecting or diagnosing tauopathies, methods of determining the effectiveness of a treatment of a tauopathy, and methods of determining whether a subject is suitable for anti-p217+ tau antibody therapy are also provided. Also described are antibodies for use in the methods and kits comprising the antibodies.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: April 13, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Hartmuth Christian Kolb, Gallen Triana-Baltzer, John Randall Slemmon
  • ASSAYS TO DETECT NEURODEGENERATION
    Publication number: 20200408781
    Abstract: Methods of measuring the amount of singly- or multiply-phosphorylated p217+ tau protein in a sample are provided. Methods of detecting or diagnosing tauopathies, methods of determining the effectiveness of a treatment of a tauopathy, and methods of determining whether a subject is suitable for anti-p217+ tau antibody therapy are also provided. Also described are antibodies for use in the methods and kits comprising the antibodies.
    Type: Application
    Filed: March 4, 2019
    Publication date: December 31, 2020
    Inventors: Hartmuth Christian Kolb, Gallen Triana-Baltzer, John Randall Slemmon
  • ASSAYS TO DETECT NEURODEGENERATION
    Publication number: 20200182888
    Abstract: Methods of measuring the amount of singly- or multiply-phosphorylated p217+ tau protein in a sample are provided. Methods of detecting or diagnosing tauopathies, methods of determining the effectiveness of a treatment of a tauopathy, and methods of determining whether a subject is suitable for anti-p217+ tau antibody therapy are also provided. Also described are antibodies for use in the methods and kits comprising the antibodies.
    Type: Application
    Filed: January 24, 2020
    Publication date: June 11, 2020
    Inventors: Hartmuth Christian Kolb, Gallen Triana-Baltzer, John Randall Slemmon
  • Assays to detect neurodegeneration
    Patent number: 10591492
    Abstract: Methods of measuring the amount of singly- or multiply-phosphorylated p217+ tau protein in a sample are provided. Methods of detecting or diagnosing tauopathies, methods of determining the effectiveness of a treatment of a tauopathy, and methods of determining whether a subject is suitable for anti-p217+ tau antibody therapy are also provided. Also described are antibodies for use in the methods and kits comprising the antibodies.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: March 17, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Hartmuth Christian Kolb, Gallen Triana-Baltzer, John Randall Slemmon
  • ASSAYS TO DETECT NEURODEGENERATION
    Publication number: 20190271710
    Abstract: Methods of measuring the amount of singly- or multiply-phosphorylated p217+ tau protein in a sample are provided. Methods of detecting or diagnosing tauopathies, methods of determining the effectiveness of a treatment of a tauopathy, and methods of determining whether a subject is suitable for anti-p217+ tau antibody therapy are also provided. Also described are antibodies for use in the methods and kits comprising the antibodies.
    Type: Application
    Filed: March 4, 2019
    Publication date: September 5, 2019
    Inventors: Hartmuth Christian Kolb, Gallen Triana-Baltzer, John Randall Slemmon
  • Method of Measuring Amyloid-Beta Peptides
    Publication number: 20090123952
    Abstract: The present invention relates to methods for measuring A? peptides in a sample, particularly a sample of blood, such as whole blood and plasma, and to methods of determining whether a compound alters the amount of A? produced by a cell or animal.
    Type: Application
    Filed: November 14, 2005
    Publication date: May 14, 2009
    Applicants: PFIZER, INC., ELAN PHARMACEUTICALS
    Inventor: John Randall Slemmon